Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinsons Disease with Dementia”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Testing effectiveness (Phase 2)Study completedNCT03305809
What this trial is testing

LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)

Who this might be right for
Lewy Body Dementia
Eli Lilly and Company 344
Not applicableLooking for participantsNCT06529744
What this trial is testing

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

Who this might be right for
DementiaAlzheimer DiseaseDementia With Lewy Bodies+7 more
University Health Network, Toronto 500
Not applicableLooking for participantsNCT06629207
What this trial is testing

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

Who this might be right for
Parkinson DiseaseREM Sleep Behavior DisorderDementia, Lewy Body
Insel Gruppe AG, University Hospital Bern 20
Not applicableEnded earlyNCT00745030
What this trial is testing

Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism

Who this might be right for
REM Behavior DisorderParkinsonism
Northwestern University 3
Not applicableEnded earlyNCT01870518
What this trial is testing

Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI

Who this might be right for
Parkinson's DiseaseMild Cognitive ImpairmentDementia
St. Joseph's Hospital and Medical Center, Phoenix 13
Not applicableActive Not RecruitingNCT06295458
What this trial is testing

Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait

Who this might be right for
Gait Disorders, NeurologicParkinson Disease
Emory University 24
Testing effectiveness (Phase 2)Looking for participantsNCT07154511
What this trial is testing

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

Who this might be right for
Parkinson DiseaseParkinson Disease Dementia
Prabesh Kanel 45
Testing effectiveness (Phase 2)UnknownNCT04167813
What this trial is testing

Trial of Ondansetron as a Parkinson's HAllucinations Treatment

Who this might be right for
Parkinson's HallucinationsDementia With Lewy Bodies
University College, London 168
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Not applicableLooking for participantsNCT05740683
What this trial is testing

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

Who this might be right for
Idiopathic AnosmiaIdiopathic HyposmiaIdiopathic Olfactory Dysfunction
Danish Dementia Research Centre 100
Very early researchLooking for participantsNCT06098612
What this trial is testing

PET Imaging Evaluation of [11C]SY08

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyDementia With Lewy Bodies+1 more
Massachusetts General Hospital 40
Very early researchStudy completedNCT06445465
What this trial is testing

Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain

Who this might be right for
Alpha-SynucleinopathyParkinson's DiseaseDementia With Lewy Bodies+1 more
Invicro 12
Not applicableStudy completedNCT01944436
What this trial is testing

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease

Who this might be right for
Lewy Body Disease
Sunnybrook Health Sciences Centre 57
Large-scale testing (Phase 3)Study completedNCT01327859
What this trial is testing

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

Who this might be right for
Parkinson's DiseaseDementia
Eisai Inc. 357
Not applicableWithdrawnNCT04055532
What this trial is testing

Biomarkers in Neurodegenerative Diseases

Who this might be right for
Mild Cognitive Impairment (MCI)Alzheimer Disease (AD)Dementia With Lewy Bodies (DLB)+8 more
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01503944
What this trial is testing

A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)

Who this might be right for
Dementia With Lewy BodiesAlzheimer's DiseaseParkinson's Disease
Avid Radiopharmaceuticals 30
Testing effectiveness (Phase 2)Looking for participantsNCT05395624
What this trial is testing

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Parkinson Disease (PD)Alzheimer Disease (AD)+1 more
Ashvattha Therapeutics, Inc. 65
Very early researchLooking for participantsNCT06891703
What this trial is testing

[18F]ACI-15916 PET in α-synucleinopathies

Who this might be right for
Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)
AC Immune SA 46
Not applicableNot Yet RecruitingNCT06978946
What this trial is testing

Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients

Who this might be right for
Alzheimer DiseaseLewy Body Dementia (LBD)Frontotemporal Dementia (FTD)+2 more
RenJi Hospital 85
Large-scale testing (Phase 3)Study completedNCT00623103
What this trial is testing

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Who this might be right for
Parkinson's Disease Dementia
Novartis 583
Load More Results